Theranostics · 2021 · 220 citations · 23 references
Life SciencesBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryNeurodegenerationAlzheimer DiseaseNeurodegenerative DiseasesNeurodegenerative DisordersProtein DegradationProtein TargetingTau PathologyAlzheimer Disease Tau PathologyAlzheimer's Disease ModelsDementia Drug DevelopmentSelective Protein DegradationTau Clearance MechanismsTau DegradationTau Protein ClearanceTau-targeted Therapy
, which provides a promising drug candidate for AD and the related tauopathies.
23
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text